Molecular and Histopathologic Characteristics of Multifocal Papillary Thyroid Carcinoma

被引:3
|
作者
Bansal, Mona [1 ]
Gandhi, Manoj [1 ]
Ferris, Robert L. [2 ]
Nikiforova, Marina N. [1 ]
Yip, Linwah [3 ]
Carty, Sally E. [3 ]
Nikiforov, Yuri E. [1 ]
机构
[1] Univ Pittsburgh, Dept Pathol & Lab Med, Sch Med, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Otolaryngol, Sch Med, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Div Endocrine Surg, Sch Med, Pittsburgh, PA 15213 USA
关键词
papillary thyroid carcinoma; multifocality; clonality; BRAF; NRAS; DISTINCT TUMOR FOCI; INDEPENDENT CLONAL ORIGIN; INTRAGLANDULAR DISSEMINATION; BRAF MUTATIONS; CANCER; REARRANGEMENTS;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Papillary thyroid carcinoma (PTC) is frequently multifocal, which can represent either intraglandular spread from a single primary tumor or multiple synchronous primary tumors (MSPTs). To distinguish and characterize these entities, we investigated whether multifocal PTCs contain genetically similar or different mutations and have particular histopathologic characteristics. In 60 cases of PTC with 2 to 4 discrete tumor foci, each focus was tested for BRAF, NRAS, HRAS, and KRAS point mutations and RET/PTC1 and RET/PTC3 rearrangements and analyzed for various histopathologic features. Overall, BRAF mutations were found in 43% of tumors, RAS in 27%, and RET/PTC in 2%. Four different patterns of mutation occurrence were identified: (i) 2 foci containing different mutations (30%); (ii) 1 tumor containing a mutation and another carrying no mutations (32%); (iii) both/all tumors containing the same mutation (25%); (iv) all tumors having no mutations (13%). The 30% of cases with 2 different mutations represent a group of tumors that are unequivocally MSPT. These tumors more commonly occurred in different lobes, although they could be located as close as 0.6 cm from each other. Moreover, MSPTs typically demonstrated distinct histologic variants/microscopic features, were encapsulated or had a smooth border, and showed no microscopic peritumoral dissemination. In conclusion, we demonstrate that at least 30% of multifocal PTCs represent unequivocal MSPTs that develop through distinct molecular alterations and that as many as 60% of multifocal PTCs are likely MSPTs. Histopathologically, MSPTs are typically located in different lobes, have distinct growth patterns, and do not show microscopic peritumoral dissemination.
引用
收藏
页码:1586 / 1591
页数:6
相关论文
共 50 条
  • [41] The oncocytic variant of papillary thyroid carcinoma with multifocal involvement: a case report
    Barut, Figen
    Ozdamar, Sukru Oguz
    Bektas, Sibel
    Tascilar, Oge
    Dodan Gun, Banu
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2010, 25 (04): : 161 - 164
  • [42] MicroRNA-based molecular classification of papillary thyroid carcinoma
    Rosignolo, Francesca
    Memeo, Lorenzo
    Monzani, Fabio
    Colarossi, Cristina
    Pecce, Valeria
    Verrienti, Antonella
    Durante, Cosimo
    Grani, Giorgio
    Lamartina, Livia
    Forte, Stefano
    Martinetti, Daniela
    Giuffrida, Dario
    Russo, Diego
    Basolo, Fulvio
    Filetti, Sebastiano
    Sponziello, Marialuisa
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (05) : 1767 - 1777
  • [43] Multicentric papillary thyroid carcinoma: a clinical analysis of 221 patients
    Zhang, Xiao-Jun
    Yang, Ting
    Li, Si-Hao
    Liu, Dan
    Xu, De-Bin
    Li, Huan
    Chen, Wen-Kuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (05): : 5680 - 5686
  • [44] Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma
    Morandi, Luca
    Righi, Alberto
    Maletta, Francesca
    Rucci, Paola
    Pagni, Fabio
    Gallo, Marco
    Rossi, Sabrina
    Caporali, Leonardo
    Sapino, Anna
    Lloyd, Ricardo V.
    Asioli, Sofia
    ENDOCRINE-RELATED CANCER, 2017, 24 (02) : 107 - 117
  • [45] Molecular analysis of structural abnormalities in papillary thyroid carcinoma genome
    Vasil'ev, EV
    Roumiantsev, PO
    Saenko, VA
    Il'in, AA
    Polyakova, EY
    Nemtsova, MV
    Zaletayev, DV
    MOLECULAR BIOLOGY, 2004, 38 (04) : 538 - 548
  • [46] Molecular rearrangements in papillary thyroid carcinomas
    Zitzelsberger, Horst
    Bauer, Verena
    Thomas, Gerry
    Unger, Kristian
    CLINICA CHIMICA ACTA, 2010, 411 (5-6) : 301 - 308
  • [47] Clinicopathologic Characteristics of Papillary Carcinoma in the Thyroid Isthmus
    Choi, Su Yun
    Kim, Jun Suk
    Soh, Euy Young
    Park, Chan Heun
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2010, 78 (02): : 77 - 81
  • [48] ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study
    Li, Qiu-li
    Chen, Fu-jin
    Lai, Renchun
    Guo, Zhu-ming
    Luo, Rongzhen
    Yang, An-kui
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1409 - 1417
  • [49] Immunohistochemical and Molecular Characteristics of Follicular Patterned Thyroid Nodules with Incomplete Nuclear Features of Papillary Thyroid Carcinoma
    Min, Hye Sook
    Choe, Gheeyoung
    Cho, Nam-Yun
    Kang, Gyeong Hoon
    Park, Seong Hoe
    Park, So Yeon
    KOREAN JOURNAL OF PATHOLOGY, 2009, 43 (06) : 495 - 502
  • [50] Activating BRAF Mutations Detected in Mixed Hurthle Cell Carcinoma and Multifocal Papillary Carcinoma of the Thyroid Gland: Report of an Unusual Case and Review of the Literature
    Sinno, Sara
    Choucair, Mahmoud
    Nasrallah, Mona
    Wadi, Lara
    Jabbour, Mark N.
    Nassif, Samer
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2016, 24 (06) : 519 - 524